Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 203 shares of common stock on October 30, 2024, to cover tax withholding obligations related to vesting restricted stock.

Summary

  • On October 30, 2024, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc., sold 203 shares of the company's common stock.
  • The sale was executed at a price of $23.15 per share.
  • Following the transaction, Aebersold directly owns 60,700 shares of BioLife Solutions Inc.
  • The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023.
  • The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) under a pre-arranged plan, so it's neutral.

Industry Context

Sales of shares by company executives are a normal part of corporate governance. Often these sales are pre-planned to avoid any accusations of insider trading.

Key Dates

DateDescription
01/03/2023Date of adoption of Rule 10b5-1(c) trading plan
10/30/2024Date of stock sale transaction
11/01/2024Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.